Evidence map›Paper›PMID 31117294›Full record

ArticleJournal of clinical medicine2019

NMR-Based Metabolomic Approach Tracks Potential Serum Biomarkers of Disease Progression in Patients with Type 2 Diabetes Mellitus.

Laura Del Coco, Daniele Vergara, Serena De Matteis, Emanuela Mensà, Jacopo Sabbatinelli, Francesco Prattichizzo, Anna Rita Bonfigli, Gianluca Storci, Sara Bravaccini, Francesca Pirini and 7 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Compound-Specific 1DACS omega · 2023
    Article
  16. Blood Metabolite Profiling of Antarctic Expedition Members: AnInternational journal of molecular sciences · 2023
    Article
  17. Review
  18. Formate Might Be a Novel Potential Serum Metabolic Biomarker for Type 2 Diabetic Peripheral Neuropathy.Diabetes, metabolic syndrome and obesity : targets and therapy · 2023
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 1 country.

Laura Del CocoDepartment of Biological and Environmental Sciences and Technologies, University of Salento, via Monteroni, 73100 Lecce, Italy. laura.delcoco@unisalento.it.
Daniele VergaraDepartment of Biological and Environmental Sciences and Technologies, University of Salento, via Monteroni, 73100 Lecce, Italy. daniele.vergara@unisalento.it.
Serena De MatteisBiosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy. serena.dematteis@irst.emr.it.
Emanuela MensàDepartment of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy. emanuela.mensa@gmail.com.
Jacopo SabbatinelliDepartment of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy. jacopo.sabbatinelli@gmail.com.
Francesco PrattichizzoIRCCS MultiMedica, 20099 Milan, Italy. francesco.prattichizzo@multimedica.it.
Anna Rita BonfigliScientific Direction, IRCCS INRCA, 60121 Ancona, Italy. a.bonfigli@inrca.it.
Gianluca StorciDepartment of Experimental, Diagnostic and Specialty Medicine, University of Bologna, 40126 Bologna, Italy. gianluca.storci@unibo.it.
Sara BravacciniBiosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy. sara.bravaccini@irst.emr.it.
Francesca PiriniBiosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy. francesca.pirini@irst.emr.it.
Andrea RagusaDepartment of Biological and Environmental Sciences and Technologies, University of Salento, via Monteroni, 73100 Lecce, Italy. andrea.ragusa@unisalento.it.
Andrea Casadei-GardiniDivision of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, 41125 Modena, Italy. casadeigardini@gmail.com.
Massimiliano BonafèDepartment of Experimental, Diagnostic and Specialty Medicine, University of Bologna, 40126 Bologna, Italy. massimiliano.bonafe@unibo.it.
Michele MaffiaDepartment of Biological and Environmental Sciences and Technologies, University of Salento, via Monteroni, 73100 Lecce, Italy. francesco.prattichizzo@multimedica.it.
Francesco Paolo FanizziDepartment of Biological and Environmental Sciences and Technologies, University of Salento, via Monteroni, 73100 Lecce, Italy. fp.fanizzi@unisalento.it.
Fabiola OlivieriDepartment of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy. f.olivieri@univpm.it.
Anna Maria GiudettiDepartment of Biological and Environmental Sciences and Technologies, University of Salento, via Monteroni, 73100 Lecce, Italy. anna.giudetti@unisalento.it.
University of Salento · ITIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori · ITMarche Polytechnic University · ITUniversity of Bologna · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITMultiMedica · ITUniversity of Modena and Reggio Emilia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by chronic hyperglycemia associated with alterations in carbohydrate, lipid, and protein metabolism. The prognosis of T2DM patients is highly dependent on the development of complications, and therefore the identification of biomarkers of T2DM progression, with minimally invasive techniques, is a huge need. In the present study, we applied a

Indexed as

branched-chain amino acidsmetabolomicsNMR spectroscopytype 2 diabetes mellitus

Identifiers

PMID31117294
PMCPMC6571571
OpenAlexW2946336271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.